Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.56
-2.19%
After-hours: Aug 15, 2025, 07:25 PM EDT

Zentalis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-162.81M -224.21M -165.87M -179.31M -194.67M -218.95M -292.28M -286.35M -285.31M -241.14M -237.11M -232.22M -188.22M -174.89M -166.09M -156.35M -180.53M -152.76M
Depreciation & Amortization
1.06M 1.23M 1.29M 1.31M 1.34M 1.35M 1.39M 1.41M 1.44M 1.44M 1.43M 1.28M 1.04M 809K 544K 368K 282K 201K
Stock-Based Compensation
54.5M 60.92M 67.27M 49.79M 53.29M 53.92M 54.82M 50.55M 47M 50.43M 46.84M 45.7M 43.04M 36.19M 35.74M 35.15M 34.75M 32.51M
Other Working Capital
8.27M 8.31M 6.48M 5.87M -431K -3.5M -5.05M -17.04M -12.32M -13.16M -13.33M 260K -3.31M -2.21M 1.35M -623K -389K 122K
Other Non-Cash Items
-32.39M -440K -66.47M -49.65M -35.02M -35.5M 27.4M 31.88M 35.1M 14.77M 12.74M 10.26M -40.55M -46M -48.21M -49.87M -114K -228K
Deferred Income Tax
n/a n/a n/a -4.16M -4.16M -4.91M -5.01M -1.62M -1.75M -917K -894K -89K 6.34M 6.75M 7.37M 7.35M 1.16M 1.1M
Change in Working Capital
-11.44M 10.98M -7.08M 10.27M 12.84M -6.42M 5.86M -421K 4.43M 12.58M 13.25M 11.64M 14.62M 10.31M 16.56M 18.92M 12.95M 11.75M
Operating Cash Flow
-151.09M -151.52M -170.86M -171.76M -166.38M -210.51M -207.82M -204.55M -199.09M -162.84M -163.75M -163.44M -163.73M -166.82M -154.09M -144.43M -131.5M -107.42M
Capital Expenditures
n/a -181K -221K -394K -485K -623K -583K -570K -2.14M -2.1M -2.55M -4.58M -5.58M -6.12M -6.11M -4.58M -1.96M -1.16M
Cash Acquisitions
504K 5K n/a 41.89K 224.25K 86K 86K 55.84K -83.19K 131.88K 131.88K 120.14K -14.18M -14.32M -14.32M -122.56M -108.24M -108.24M
Purchase of Investments
-158.17M -137.38M -127.96M -184.73M -389.61M -495.42M -549.18M -579.18M -444.67M -517.79M -533.16M -490.4M -563.27M -388.33M -363.51M -377.18M -341.56M -455.42M
Sales Maturities Of Investments
308.98M 292.98M 304.68M 287.28M 326.55M 471.01M 505.31M 565.46M 569.99M 428.03M 421.53M 435.96M 362.69M 396.99M 365.82M 325.05M 276.04M 185.24M
Other Investing Acitivies
65K 65K 65K 23.11K -159.25K -86K -43.88K -13.72K 125.32K -89.76K 20.11M 65.58M 51.24M 118.81M 112.45M 175.23M 218.55M 13.89M
Investing Cash Flow
151.38M 155.49M 176.56M 102.22M -63.48M -25.03M -44.46M -14.29M 123.18M -91.86M -114.18M -59.02M -220.48M -11.78M -18.11M -71.03M -67.48M -271.34M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
349K 349K 108K -241K -241K -241K n/a n/a n/a n/a n/a -1.15M -760K -1.15M -1.15M n/a -386K 191.66M
Financial Cash Flow
281K 290K 108K 108K 325K 236.94M 237.3M 287.04M 287.32M 260.16M 261.04M 223.57M 389.55M 179.78M 178.52M 165.66M 154.99M 346.96M
Net Cash Flow
569K 4.26M 5.81M -69.48M -229.58M 1.34M -15.03M 68.2M 211.41M 5.46M -16.89M 1.11M 5.34M 1.18M 6.31M -49.8M -43.99M -31.8M
Free Cash Flow
-151.09M -151.7M -171.08M -172.15M -166.86M -211.14M -208.41M -205.12M -201.22M -164.94M -166.3M -168.02M -169.31M -172.94M -160.2M -149.01M -133.46M -108.59M